Candel Therapeutics, Inc. financial statements
Candel Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 38.18M | 10-K |
| Cash and equivalents | USD 119.73M | 10-Q |
| Total debt | USD 0 | 10-K |
Candel Therapeutics, Inc. financials on 6ix · Candel Therapeutics, Inc. on 6ix